These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

672 related articles for article (PubMed ID: 26336867)

  • 1. Cognitive heterogeneity in adult attention deficit/hyperactivity disorder: A systematic analysis of neuropsychological measurements.
    Mostert JC; Onnink AMH; Klein M; Dammers J; Harneit A; Schulten T; van Hulzen KJE; Kan CC; Slaats-Willemse D; Buitelaar JK; Franke B; Hoogman M
    Eur Neuropsychopharmacol; 2015 Nov; 25(11):2062-2074. PubMed ID: 26336867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delay Aversion and Executive Functioning in Adults With Attention-Deficit/Hyperactivity Disorder: Before and After Stimulant Treatment.
    Low AM; le Sommer J; Vangkilde S; Fagerlund B; Glenthøj B; Sonuga-Barke E; Habekost T; Jepsen JRM
    Int J Neuropsychopharmacol; 2018 Nov; 21(11):997-1006. PubMed ID: 30124878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of stimulant medication on neuropsychological functioning in young adults with attention-deficit/hyperactivity disorder.
    Biederman J; Seidman LJ; Petty CR; Fried R; Doyle AE; Cohen DR; Kenealy DC; Faraone SV
    J Clin Psychiatry; 2008 Jul; 69(7):1150-6. PubMed ID: 18517288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting impairment in major life activities and occupational functioning in hyperactive children as adults: self-reported executive function (EF) deficits versus EF tests.
    Barkley RA; Fischer M
    Dev Neuropsychol; 2011; 36(2):137-61. PubMed ID: 21347918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinguishing sluggish cognitive tempo from attention-deficit/hyperactivity disorder in adults.
    Barkley RA
    J Abnorm Psychol; 2012 Nov; 121(4):978-90. PubMed ID: 21604823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative neuropsychology of adult obsessive-compulsive disorder and attention deficit/hyperactivity disorder: implications for a novel executive overload model of OCD.
    Abramovitch A; Dar R; Hermesh H; Schweiger A
    J Neuropsychol; 2012 Sep; 6(2):161-91. PubMed ID: 22257360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive complaints and neuropsychological functioning in adults with and without attention-deficit hyperactivity disorder referred for multidisciplinary assessment.
    In de Braek D; Dijkstra JB; Jolles J
    Appl Neuropsychol; 2011 Apr; 18(2):127-35. PubMed ID: 21660764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive variability in adults with ADHD and AS: disentangling the roles of executive functions and social cognition.
    Gonzalez-Gadea ML; Baez S; Torralva T; Castellanos FX; Rattazzi A; Bein V; Rogg K; Manes F; Ibanez A
    Res Dev Disabil; 2013 Feb; 34(2):817-30. PubMed ID: 23220737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deviant white matter structure in adults with attention-deficit/hyperactivity disorder points to aberrant myelination and affects neuropsychological performance.
    Onnink AM; Zwiers MP; Hoogman M; Mostert JC; Dammers J; Kan CC; Vasquez AA; Schene AH; Buitelaar J; Franke B
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Dec; 63():14-22. PubMed ID: 25956761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive and emotional impairments in adults with attention-deficit/hyperactivity disorder and cocaine use.
    Wunderli MD; Vonmoos M; Niedecker SM; Hulka LM; Preller KH; Baumgartner MR; Kraemer T; Seifritz E; Schaub MP; Eich-Höchli D; Quednow BB
    Drug Alcohol Depend; 2016 Jun; 163():92-9. PubMed ID: 27085500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OROS-methylphenidate efficacy on specific executive functioning deficits in adults with ADHD: a randomized, placebo-controlled cross-over study.
    Bron TI; Bijlenga D; Boonstra AM; Breuk M; Pardoen WF; Beekman AT; Kooij JJ
    Eur Neuropsychopharmacol; 2014 Apr; 24(4):519-28. PubMed ID: 24508533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Could comorbid bipolar disorder account for a significant share of executive function deficits in adults with attention-deficit hyperactivity disorder?
    Silva KL; Rovaris DL; Guimarães-da-Silva PO; Victor MM; Salgado CA; Vitola ES; Contini V; Bertuzzi G; Picon FA; Karam RG; Belmonte-de-Abreu P; Rohde LA; Grevet EH; Bau CH
    Bipolar Disord; 2014 May; 16(3):270-6. PubMed ID: 24286629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional impairment in adults positively screened for attention-deficit hyperactivity disorder: the role of symptom presentation and executive functioning.
    Szuromi B; Bitter I; Czobor P
    Compr Psychiatry; 2013 Oct; 54(7):974-81. PubMed ID: 23684546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Executive function assessment and adult attention-deficit/hyperactivity disorder: tasks versus ratings on the Barkley deficits in executive functioning scale.
    Kamradt JM; Ullsperger JM; Nikolas MA
    Psychol Assess; 2014 Dec; 26(4):1095-105. PubMed ID: 24885846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive complaints of adults with attention deficit hyperactivity disorder.
    Fuermaier AB; Tucha L; Koerts J; Aschenbrenner S; Weisbrod M; Lange KW; Tucha O
    Clin Neuropsychol; 2014; 28(7):1104-22. PubMed ID: 25270667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Executive function and attention deficit hyperactivity disorder: stimulant medication and better executive function performance in children.
    Kempton S; Vance A; Maruff P; Luk E; Costin J; Pantelis C
    Psychol Med; 1999 May; 29(3):527-38. PubMed ID: 10405075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No lower cognitive functioning in older adults with attention-deficit/hyperactivity disorder.
    Semeijn EJ; Korten NC; Comijs HC; Michielsen M; Deeg DJ; Beekman AT; Kooij JJ
    Int Psychogeriatr; 2015 Sep; 27(9):1467-76. PubMed ID: 25655491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testing the dual pathway model of ADHD in obesity: a pilot study.
    Van der Oord S; Braet C; Cortese S; Claes L
    Eat Weight Disord; 2018 Aug; 23(4):507-512. PubMed ID: 28271452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinguishing sluggish cognitive tempo from ADHD in children and adolescents: executive functioning, impairment, and comorbidity.
    Barkley RA
    J Clin Child Adolesc Psychol; 2013; 42(2):161-73. PubMed ID: 23094604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.